Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Organocatalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114524701B reveals a novel chiral phosphoric acid catalyzed synthesis of N-N axis chiral pyrroles with high enantioselectivity and cytotoxic activity.
Patent CN112920173A details a mild, high-yield synthesis of chiral chromans with potent anticancer activity, offering reliable supply chain solutions.
Novel organocatalytic route for high-purity axial chiral indole-naphthalenes. Cost-effective, scalable process for chiral catalyst precursors and pharmaceutical intermediates.
Patent CN110452150B details a novel chiral phosphoric acid catalyzed synthesis of axial chiral indole-naphthalenes, offering high enantioselectivity and scalable manufacturing for advanced catalytic applications.
Patent CN117820316B reveals a novel chiral phosphoric acid catalyzed route for high-purity indolo compounds with significant cost reduction in API manufacturing and supply chain reliability.
Discover the novel organocatalytic synthesis of N-N axis chiral bisindoles via patent CN116082217B. High enantioselectivity and cytotoxic activity for advanced drug development.
Patent CN110467555B reveals a chiral phosphoric acid catalyzed route for high-purity indole-naphthalene intermediates, offering mild conditions and superior enantioselectivity for scalable API production.
Novel chiral phosphoric acid catalyzed synthesis of N-N axis pyrroles. High yield, mild conditions, scalable for pharma intermediates.
Novel organocatalytic route for high-purity axial chiral indole-naphthalenes. Cost-effective, scalable process for asymmetric catalysis intermediates.
Patent CN108558692B reveals a mild N-heterocyclic carbene catalyzed route for amide bond formation, offering significant cost reduction in API manufacturing and superior supply chain reliability.
Patent CN109265403B reveals a novel benzimidazole synthesis method using imidazole hydrochloride, offering high yields and mild conditions for reliable pharmaceutical intermediate supply.
Patent CN110452150B discloses a novel organocatalytic route for high-purity axial chiral indole-naphthalenes. This method offers significant cost reduction in chiral catalyst manufacturing and scalable production capabilities.
Patent CN102766092A details a mild chiral spiro phosphoric acid catalyzed synthesis of optically active tetrahydroquinolines, offering high enantioselectivity and simplified purification for API manufacturing.
Novel chiral phosphoric acid catalyzed resolution method for axially chiral oxindole-substituted styrenes. High ee values up to 96%. Ideal for pharma intermediates.
Breakthrough axial chiral catalyst enables high-purity API intermediates with enhanced stereoselectivity and scalable manufacturing advantages.
Patent CN108976238A enables high-yield chiral synthesis of bis-trifluoromethyl spirooxindoles with excellent stereoselectivity, offering reliable supply and cost reduction for pharmaceutical intermediates.
Patent CN102659494A enables high-purity oxindole synthesis with mild conditions, reducing lead time and manufacturing costs for pharmaceutical intermediates.